Supreme Court Myriad decision: a panel discussion
Monday, July 1, 2013 from 6:00 PM to 8:00 PM (EDT)
New York, NY
San Francisco, California
London, United Kingdom
Panel speakers include
1. John Murray of THSH
John is originally from Bangor, Northern Ireland. He received his Ph.D. under the supervision of Professor Sir Alec J. Jeffreys from the University of Leicester, England. Prior to achieving his Ph.D. he studied genetics at the University of Edinburgh, Scotland. His Ph.D. thesis concerned the study of recombination mechanisms in human minisatellite DNA.
After receiving his Ph.D., John became a Post-Doctoral Fellow in New York under the supervision of Dr. Larry Shapiro at Mt. Sinai School of Medicine and later Columbia University. His post-doctoral work studied the structure of calcium-dependent cell adhesion molecules through the use of x-ray crystallography. John's practice focuses on complex life sciences litigation, prosecution and opinion work. He has particular experience in Hatch-Waxman litigation, biotechnology and medical device prosecution and generic pharmaceuticals opinion work.
2. Hans Saur of Bio, Joseph Robinson of Troutman Sanders
Hans Sauer is Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO), a major trade association representing over 1,100 biotechnology companies from the medical, agricultural, environmental, and industrial sector. At BIO, Mr. Sauer advises the organization's board of directors, amicus committee, and various staff committees on patent and other intellectual property-related matters. Prior to his current position, Mr. Sauer was Chief Patent Counsel for MGI Pharma, Inc., and Senior Patent Counsel for Guilford Pharmaceuticals Inc. Mr. Sauer has 13 years of professional in-house experience in the biotechnology industry, where he worked on several research and drug development programs, being responsible for patent prosecution and portfolio oversight, clinical trial health information privacy, and sales and marketing legal compliance. Mr. Sauer has an M.S. degree in Biology from the University of Ulm in his native Germany, a Ph.D. in Neuroscience from the University of Lund, Sweden, and a J.D. from Georgetown University Law Center in Washington, D.C.
3. Mitchell Wong of the Exeter Law Group
Mitchell M. Wong is one of only several American litigators qualified to practice across three continents: he is admitted in New York, England and Wales, and Hong Kong. In addition, he is a licensed patent practitioner in both the United States and Canada. Mr. Wong’s practice focuses on complex commercial disputes and intellectual-property litigation.
Mr. Wong has been responsible for numerous proceedings, including patent matters in both the federal courts and before the U.S. Patent & Trademark Office (in both inter partes and ex parte proceedings). In 2008, the New York State Legislature called Mr. Wong to testify as an impartial witness on the role of pharmaceutical patents in the commercialization of generic drugs. He has been appointed a Special Master for civil cases before the New York State Supreme Court
4. Laura Coruzzi of Jones Day
Dr. Laura Coruzzi has represented clients in biotechnology and pharmaceuticals for close to 30 years. Prior to joining Jones Day, she practiced at Pennie & Edmonds LLP and was one of the first members of that firm's biotechnology group founded by S. Leslie Misrock, affectionately known as the "father of biotechnology patent law." Laura's practice has evolved with the patent laws and matured with the needs of the biotechnology and pharmaceutical industries. Her practice involves all aspects of patent law as it relates to a variety of disciplines in the life sciences, including genetic engineering, molecular biology, virology, vaccines, immunology, therapeutic antibodies, biologic and small molecule therapeutics, diagnostics, drug discovery, and drug delivery.
5. Kristin Neuman of MPEG LA.
Kristin Neuman is the Executive Director of Librassay, a web-based patent licensing facility for diagnostics, biomarkers and related research tools in support of the new age of personalized medicine. Librassay® is sponsored by MPEG LA, the world's leader in patent pools and other one-stop IP licensing solutions.
Prior to joining MPEG LA in February of this year, Kristin was a senior intellectual property lawyer with Proskauer Rose, a large global law firm headquartered in New York City. Her practice focused on patent procurement, IP litigation, licensing and other business transactions in the fields of molecular diagnostics, biotechnology, pharmaceuticals and medical devices.
Kristin frequently writes and lectures on topics relating to patent law and the intersection of intellectual property, business and entrepreneurism.
Kristin holds a Bachelor of Arts in Biochemistry, Phi Beta Kappa, from the University of Colorado and a Juris Doctor from the Georgetown University Law Center. Prior to entering private practice, she clerked for the Honorable Roger B. Andewelt of the U.S. Court of Federal Claims in Washington, D.C.
She is also a board member of NYC Bio